Search results for: 'poct 88'
- Related search terms
- poct cancer
- poct rsv adenoviruses influenza
- poct part analysis for laboratory develop
- POCT software®ions=234
- poct and saa market
-
16 Feb 2021  |  North America  |  Market Research
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market
Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care
Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...
$2,450.00
Special Price $1,837.50 save 25 %
-
15 Nov 2023  |  North America  |  Market Research
Global Point-of-care Testing Growth Opportunities
Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural s...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Sep 2020  |  North America  |  Market Research
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2018  |  North America  |  Market Research
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...
$1,500.00
Special Price $1,125.00 save 25 %
-
20 Jul 2020  |  North America  |  Market Research
Opportunities and Use Cases for Autonomous Trucking, Forecast to 2040
Level 1 and Level 2 Vehicles will Account for Around 88% Share of the Overall M&HCV Market, and Level 4 Around 12%, by 2040. Autonomous Trucks will Enable Annual Savings of $4.75 Billion in General Freight Alone by 2030 in the United States
Global trucking demand is on the rise with the consistent increase in capacity, need for faster transfer influenced by economic developments, new business ventures, and changing buying patterns. However, the trucking industry in general is plagued by concerns like driver shortage, vehicle price increases, fuel price volatility, road safety, and per...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Jul 2021  |  North America  |  Market Research
North American Light Commercial Vehicle Growth Opportunities
The Overall LCV Market in North America is Expected to Grow to 5.0 Million Units by 2025, with New Product Development in EVs Helping it Achieve a Penetration of 6.2%
The overall light commercial vehicle (LCV) market in North America was at 3.74 million units in 2020 with pickups contributing 88% of those volumes. Within the LCV segment, the lower weight segment, class 1/2a (
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Nov 2022  |  North America  |  Market Research
Cardiac Troponin Diagnostics—Forecasts and Opportunities to 2025
Demand for High Sensitivity Point-of-Care Testing Enhance Growth Potential
Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2016  |  North America  |  Market Research
Growth Opportunities in the US Point-of-care Testing Market
Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Jul 2015  |  North America  |  Market Research
Analysis of the US and European Diabetes Diagnostics Market
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
$6,950.00
Special Price $5,212.50 save 25 %
-
02 May 2018  |  North America  |  Technology Research
Breakthrough Innovations in PoC Diagnostics for Smart Healthcare
Rapid, Accessible, and Affordable Diagnostics Augmenting Healthcare
Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...
$4,950.00
Special Price $3,712.50 save 25 %